How many insider trades does FilingIQ track for MIRA?

FilingIQ tracks 39 Form 4 insider transactions for MIRA (MIRA PHARMACEUTICALS, INC.), covering filings from Aug 2, 2023 onwards. 1 of those were filed in the last 90 days.

Are MIRA insiders net buyers or net sellers?

Across the full Form 4 history for MIRA, 10 transactions (26%) were open-market purchases and 25 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MIRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MIRA in?

MIRA PHARMACEUTICALS, INC. (MIRA) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $46.90M.

MIRA insider trading

NasdaqCM Healthcare

MIRA PHARMACEUTICALS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

26% / 64%

Market cap

$46.90M

About MIRA PHARMACEUTICALS, INC.

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.

Company website: mirapharmaceuticals.com

MIRA insider activity at a glance

FilingIQ has scored 39 insider transactions for MIRA since Aug 2, 2023. The most recent filing in our index is dated Mar 30, 2026.

Across the full history, 10 open-market purchases and 25 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MIRA insider trades is 52.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MIRA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MIRA?: FilingIQ tracks 39 Form 4 insider transactions for MIRA (MIRA PHARMACEUTICALS, INC.), covering filings from Aug 2, 2023 onwards. 1 of those were filed in the last 90 days.
Are MIRA insiders net buyers or net sellers?: Across the full Form 4 history for MIRA, 10 transactions (26%) were open-market purchases and 25 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MIRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MIRA in?: MIRA PHARMACEUTICALS, INC. (MIRA) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $46.90M.

Methodology & sources

Every MIRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.